BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Annals of Oncology Année : 2017

BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial

Dates et versions

hal-02329710 , version 1 (23-10-2019)

Identifiants

Citer

T. Petrella, C. Copie-Bergman, J. Brière, R. Delarue, F. Jardin, et al.. BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial. Annals of Oncology, 2017, 28 (5), pp.1042-1049. ⟨10.1093/annonc/mdx022⟩. ⟨hal-02329710⟩
38 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More